Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
260,50 € ↑8,70 (3,46%)
2026-06-04
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionCapital Fund Management S.a.
Latest Disclosed Ownership140,109 shares
Latest Disclosed Value $ 46,357,864
Capital Fund Management S.a. ownership in DUL / Alnylam Pharmaceuticals, Inc.

On May 14, 2026 - Capital Fund Management S.a. filed a 13F-HR form disclosing ownership of 140,109 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $40,029,141 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 20,940 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of 569.10% during the quarter. The current value of the position is $36,498,394 USD.

Capital Fund Management S.a. has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ALNYLAM PHARMACEUTICALS INC COM ALNYLAM PHARMACEUTICALS INC COM 02043Q107 140,109 119,169 569.10 46,358 456.77 0.2095
2026-02-17 2025-12-31 13F ALNYLAM PHARMACEUTICALS INC COM ALNYLAM PHARMACEUTICALS INC COM 02043Q107 20,940 20,940 8,327 0.0231
2024-11-13 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -41,821 -100.00 0 -100.00
2024-08-13 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 41,821 11,454 37.72 10,163 123.93 0.0299
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 30,367 30,367 4,538 0.0131
2020-08-13 2020-06-30 13F Alnylam Pharmaceuticals COM 02043Q107 0 -8,332 -100.00 0 -100.00
2020-05-13 2020-03-31 13F Alnylam Pharmaceuticals COM 02043Q107 8,332 8,332 907 0.0140
2019-02-13 2018-12-31 13F Alnylam Pharmaceuticals COM 02043Q107 0 -5,127 -100.00 0 -100.00
2018-11-14 2018-09-30 13F Alnylam Pharmaceuticals COM 02043Q107 5,127 5,127 449 0.0024
2018-05-15 2018-03-31 13F Alnylam Pharmaceuticals COM 02043Q107 0 -1,674 -100.00 0 -100.00
2018-02-09 2017-12-31 13F Alnylam Pharmaceuticals COM 02043Q107 1,674 1,674 213 0.0012
2016-10-31 2016-09-30 13F Alnylam Pharmaceuticals COM 02043Q107 0 -49,622 -100.00 0 -100.00
2016-07-27 2016-06-30 13F Alnylam Pharmaceuticals COM 02043Q107 49,622 -9,828 -16.53 2,754 -26.21 0.0258
2016-05-02 2016-03-31 13F Alnylam Pharmaceuticals COM 02043Q107 59,450 59,450 0.00 3,732 0.0362
2016-01-28 2015-12-31 13F Alnylam Pharmaceuticals COM 02043Q107 0 -32,956 -100.00 0 -100.00
2015-10-27 2015-09-30 13F Alnylam Pharmaceuticals COM 02043Q107 32,956 22,749 222.88 2,648 116.34 0.0296
2015-07-28 2015-06-30 13F Alnylam Pharmaceuticals COM 02043Q107 10,207 -5,964 -36.88 1,224 -27.53 0.0155
2015-04-28 2015-03-31 13F Alnylam Pharmaceuticals COM 02043Q107 16,171 -240 -1.46 1,689 53.27 0.0230
2014-05-14 2014-03-31 13F Alnylam Pharmaceuticals COM 02043Q107 16,411 1,825 12.51 1,102 17.48 0.0135
2014-01-31 2013-12-31 13F Alnylam Pharmaceuticals COM 02043Q107 14,586 14,586 938 0.0116
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-08-13 2020-06-30 13F Alnylam Pharmaceuticals COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F Alnylam Pharmaceuticals COM Call 13,800 360.00 1,502 334.10 n/a n/a n/a
2020-02-13 2019-12-31 13F Alnylam Pharmaceuticals COM Call 3,000 346 n/a n/a n/a
2019-02-13 2018-12-31 13F Alnylam Pharmaceuticals COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F Alnylam Pharmaceuticals COM Call 30,600 101.32 2,678 78.89 n/a n/a n/a
2018-08-14 2018-06-30 13F Alnylam Pharmaceuticals COM Call 15,200 -32.14 1,497 -43.89 n/a n/a n/a
2018-05-15 2018-03-31 13F Alnylam Pharmaceuticals COM Call 22,400 -20.28 2,668 -25.27 n/a n/a n/a
2018-02-09 2017-12-31 13F Alnylam Pharmaceuticals COM Call 28,100 1,305.00 3,570 1,419.15 n/a n/a n/a
2017-11-13 2017-09-30 13F Alnylam Pharmaceuticals COM Call 2,000 235 n/a n/a n/a
2017-05-03 2017-03-31 13F Alnylam Pharmaceuticals COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-08 2016-12-31 13F Alnylam Pharmaceuticals COM Call 7,800 292 n/a n/a n/a
2016-07-27 2016-06-30 13F Alnylam Pharmaceuticals COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-02 2016-03-31 13F Alnylam Pharmaceuticals COM Call 9,000 119.51 565 105.45 n/a n/a n/a
2014-05-14 2014-03-31 13F Alnylam Pharmaceuticals COM Call 4,100 -55.91 275 -53.78 n/a n/a n/a
2014-01-31 2013-12-31 13F Alnylam Pharmaceuticals COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2013-10-31 2013-09-30 13F Alnylam Pharmaceuticals COM Call 9,300 595 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-08-13 2020-06-30 13F Alnylam Pharmaceuticals COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F Alnylam Pharmaceuticals COM Put 9,900 1,078 n/a n/a n/a
2019-02-13 2018-12-31 13F Alnylam Pharmaceuticals COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F Alnylam Pharmaceuticals COM Put 22,400 183.54 1,960 151.93 n/a n/a n/a
2018-08-14 2018-06-30 13F Alnylam Pharmaceuticals COM Put 7,900 276.19 778 211.20 n/a n/a n/a
2018-05-15 2018-03-31 13F Alnylam Pharmaceuticals COM Put 2,100 -92.76 250 -93.21 n/a n/a n/a
2018-02-09 2017-12-31 13F Alnylam Pharmaceuticals COM Put 29,000 935.71 3,684 1,019.76 n/a n/a n/a
2017-11-13 2017-09-30 13F Alnylam Pharmaceuticals COM Put 2,800 0.00 329 47.53 n/a n/a n/a
2017-08-10 2017-06-30 13F Alnylam Pharmaceuticals COM Put 2,800 223 n/a n/a n/a
2016-07-27 2016-06-30 13F Alnylam Pharmaceuticals COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-02 2016-03-31 13F Alnylam Pharmaceuticals COM Put 3,500 -23.91 220 -28.80 n/a n/a n/a
2014-05-14 2014-03-31 13F Alnylam Pharmaceuticals COM Put 4,600 -22.03 309 -18.25 n/a n/a n/a
2014-01-31 2013-12-31 13F Alnylam Pharmaceuticals COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2013-10-31 2013-09-30 13F Alnylam Pharmaceuticals COM Put 5,900 378 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.